NUSCAN
DEAD

Serial Number

97130050

Owner

PRECEDE BIOSCIENCES, INC.

Attorney

Caitlin R. Byczko

Filing Date

Nov 17, 2021

Add to watchlist:

No watchlists yet
View on USPTO

NUSCAN Trademark

Serial Number: 97130050

NUSCAN is a trademark filed by PRECEDE BIOSCIENCES, INC. on November 17, 2021. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 44 (Medical Services). The application is currently no longer active.

Owner Contact Info

PRECEDE BIOSCIENCES, INC. (9 trademarks)

1 Design Center Place, 5th Floor
Boston, MA 02210

Entity Type: 03

Nuscan Diagnostics, Inc. (6 trademarks)

200 Clarendon Street, 45th Floor
Boston, MA 02116

Entity Type: 03

Trademark Details

Filing Date

November 17, 2021

Registration Date

Not Registered

Published for Opposition

October 17, 2023

Goods & Services

diagnostic assays and reagents for clinical and medical use, namely for the testing of body fluids; diagnostic chemical, biochemical and biological preparations for medical purposes, namely for treating and preventing cancers and other clinical pathologies; diagnostic test kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely cancers

medical testing and diagnostic services, namely, testing for medical diagnostic or treatment purposes in the field of cancer, autoimmune disease, maternal fetal medicine; clinical pathology services, namely, medical testing for diagnostic or treatment purposes in the field of clinical pathology; medical analysis services for diagnostic and treatment purposes relating to the treatment of persons; medical testing for diagnostic or treatment purposes in the field of pathology relating to the treatment of persons; medical diagnostic testing, monitoring and reporting services

testing instruments for medical diagnostic purposes, namely, instruments for medical diagnostic testing in the field of cancer; medical devices, namely, automated medical diagnostic image analyzers featuring a system consisting of computer hardware as a component of the medical devices, for use in detecting epigenetic signatures in the field of clinical pathology; diagnostic testing kits consisting primarily of probes, buffer, and reagent for use in microbial testing

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Jan 13, 2025 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Jan 13, 2025 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 14, 2024 EXRA
SOU EXTENSION 1 GRANTED
May 13, 2024 EX1G
SOU EXTENSION 1 FILED
May 13, 2024 EXT1
SOU TEAS EXTENSION RECEIVED
May 13, 2024 EEXT
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Feb 6, 2024 TCCA
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Feb 6, 2024 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Feb 6, 2024 COAR
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Dec 12, 2023 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 17, 2023 NPUB
PUBLISHED FOR OPPOSITION
Oct 17, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 27, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 8, 2023 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 8, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 8, 2023 CRFA
EXAMINER'S AMENDMENT ENTERED
Sep 8, 2023 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Sep 8, 2023 GNEN
EXAMINERS AMENDMENT E-MAILED
Sep 8, 2023 GNEA
EXAMINERS AMENDMENT -WRITTEN
Sep 8, 2023 CNEA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Jun 23, 2023 ERSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Mar 9, 2023 GNS3
LETTER OF SUSPENSION E-MAILED
Mar 9, 2023 GNSL
SUSPENSION LETTER WRITTEN
Mar 9, 2023 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 1, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 28, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 28, 2023 TROA
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Feb 8, 2023 ASGN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 29, 2022 GNRN
NON-FINAL ACTION E-MAILED
Aug 29, 2022 GNRT
NON-FINAL ACTION WRITTEN
Aug 29, 2022 CNRT
ASSIGNED TO EXAMINER
Aug 29, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 23, 2021 NWOS
NEW APPLICATION ENTERED
Nov 20, 2021 NWAP